We are live on ! Find out more
NH

NantHealth, Inc

Delisted

NH was delisted on the 23rd of May, 2023.

45 hedge funds and large institutions have $18.8M invested in NantHealth, Inc in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 15

5% less capital invested

Capital invested by funds: $19.7M → $18.8M (-$900K)

8% less funds holding

Funds holding: 4945 (-4)

37% less call options, than puts

Call options by funds: $500K | Put options by funds: $797K

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
45
Holders Change
-4
Holders Change %
-8.16%
% of All Funds
0.79%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
19
Reduced
15
Closed
9
Calls
$500K
Puts
$797K
Net Calls
-$297K
Net Calls Change
+$389K
Name Holding Trade Value Shares
Change
Change in
Stake
Acadian Asset Management
51
Acadian Asset Management
Massachusetts
-$27K -556 Closed
PAM
52
Panagora Asset Management
Massachusetts
-$4K -88 Closed
ASN
53
Advisory Services Network
Georgia
-$2K -33 Closed

NH Hedge Fund Activity: Q1 2021 in Review

45 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in NantHealth, Inc (NH) for Q1 2021, worth a combined $18.8M — down 4.6% from $19.7M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of NH and 5 opened new positions — a net loss of 4 holders — while 15 trimmed existing stakes and 19 added.

The largest buyer was JP Morgan Chase, adding an estimated $468K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $917K sold.

  • 45 institutional investors held NantHealth, Inc (NH) as of Q1 2021, down from 49 in Q4 2020.
  • Funds reported $18.8M of NantHealth, Inc stock for Q1 2021, down 4.6% quarter-over-quarter.
  • 5 funds opened new NantHealth, Inc positions in Q1 2021 and 9 closed out, a net change of -4 holders.
  • The largest NantHealth, Inc buyer in Q1 2021 was JP Morgan Chase, an estimated $468K added.
  • The largest NantHealth, Inc seller in Q1 2021 was Renaissance Technologies, an estimated $917K sold.

Based on aggregated 13F filings for Q1 2021.